3,4-dihydroxyphenylacetic acid has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muñoz, RM; Navarro, M; Rodríguez de Fonseca, FR; San-Martin-Clark, O; Villanúa, MA | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol
| Article | Year |
|---|---|
Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Dopamine Agonists; Dorsomedial Hypothalamic Nucleus; Dronabinol; Hormones; Male; Neurosecretory Systems; Norepinephrine; Pituitary Gland; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate | 1995 |